For women struggling with weight gain after menopause, a new study suggests that adding hormone therapy to a popular obesity drug may lead to greater weight loss. Postmenopausal women lost about 35% ...
Bone loss. Basically, any time you lose weight, whether it’s through a GLP-1 or lifestyle changes, there’s the potential for ...
Women treated with GLP-1 for weight loss show significantly higher rates of weight loss compared with men, but notably, no significant differences are observed in a variety of other patient ...
Weight loss drugs give women with PMOS new hope in fight against hormonal disorder - An expanding body of research indicates ...
Postmenopausal women may have a powerful new edge in the battle against weight gain. A Mayo Clinic study found that those using menopausal hormone therapy while taking the obesity drug tirzepatide ...
A personalized approach to obesity treatment may help breast cancer survivors improve their long-term health by identifying ...
GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounarjo, Zepbound) can do a lot — often, a whole lot — to help manage conditions like obesity and diabetes and improve overall ...
It's totally possible to change your body composition in midlife and beyond.